Candida albicans-induzierte Genexpression in primären ... - OPUS

inflamed epithelial surfaces and is the most potent chemokine known in
attracting Langerhans cell precursors. J Exp Med, 192, 705-718.
35. Dong, C., Davis, R.J. and Flavell, R.A. (2002) MAP kinases in the immune
response. Annu Rev Immunol, 20, 55-72.
36. Dostert, C. and Tschopp, J. (2007) DEteCTINg fungal pathogens. Nat
Immunol, 8, 17-18.
37. Edmond, M.B., Wallace, S.E., McClish, D.K., Pfaller, M.A., Jones, R.N. and
Wenzel, R.P. (1999) Nosocomial bloodstream infections in United States
hospitals: a three-year analysis. Clin Infect Dis, 29, 239-244.
38. Englert, C., Hou, X., Maheswaran, S., Bennett, P., Ngwu, C., Re, G.G.,
Garvin, A.J., Rosner, M.R. and Haber, D.A. (1995) WT1 suppresses synthesis
of the epidermal growth factor receptor and induces apoptosis. Embo J, 14,
4662-4675.
39. Faure, E., Equils, O., Sieling, P.A., Thomas, L., Zhang, F.X., Kirschning, C.J.,
Polentarutti, N., Muzio, M. and Arditi, M. (2000) Bacterial lipopolysaccharide
activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human
dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in
endothelial cells. J Biol Chem, 275, 11058-11063.
40. Filler, S.G., Pfunder, A.S., Spellberg, B.J., Spellberg, J.P. and Edwards, J.E.,
Jr. (1996) Candida albicans stimulates cytokine production and leukocyte
adhesion molecule expression by endothelial cells. Infect Immun, 64, 2609-
2617.
41. Filler, S.G., Swerdloff, J.N., Hobbs, C. and Luckett, P.M. (1995) Penetration
and damage of endothelial cells by Candida albicans. Infect Immun, 63, 976-
983.
42. Fradin, C., Mavor, A.L., Weindl, G., Schaller, M., Hanke, K., Kaufmann, S.H.,
Mollenkopf, H. and Hube, B. (2007) The early transcriptional response of
human granulocytes to infection with Candida albicans is not essential for
killing but reflects cellular communications. Infect Immun, 75, 1493-1501.
43. Gantner, B.N., Simmons, R.M., Canavera, S.J., Akira, S. and Underhill, D.M.
(2003) Collaborative induction of inflammatory responses by dectin-1 and Tolllike
receptor 2. J Exp Med, 197, 1107-1117.
120